Tuberculosis (TB) remains a significant global health challenge, necessitating improved diagnostic methods for effective control and eradication. This article presents a comprehensive review of the contemporary diagnostic approaches for TB in healthcare settings.
Advancements in molecular biology have led to the development of rapid, sensitive and specific diagnostic tools for TB. Techniques such as Polymerase Chain Reaction (PCR) and Whole Genome Sequencing (WGS) have revolutionized TB diagnostics, facilitating early detection and precise identification of drug-resistant strains.
Imaging techniques like Chest X-rays and Computed Tomography (CT) scans remain integral in TB diagnostics, providing visual evidence of pulmonary abnormalities. However, these techniques are less effective in detecting extrapulmonary TB and in patients co-infected with HIV.
Immunological tests such as the Tuberculin Skin Test (TST) and the Interferon Gamma Release Assays (IGRAs) are widely used for TB diagnosis. While TST is simple and inexpensive, it has limitations in specificity and sensitivity. IGRAs, on the other hand, offer better specificity but are more expensive and require sophisticated laboratory infrastructure.
Microbiological techniques like sputum smear microscopy and culture remain the gold standard for TB diagnosis. However, these methods are time-consuming and have reduced sensitivity in patients with paucibacillary disease or children.
While significant advancements have been made in TB diagnostics, no single technique is universally applicable due to variations in sensitivity, specificity, cost, and infrastructural requirements. An effective diagnostic approach should, therefore, incorporate a combination of these techniques tailored to the specific needs of the patient population and healthcare setting. Continued research and innovation are imperative to unmask TB and curb its global impact.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation